ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA)

Historical Holders from Q2 2014 to Q3 2025

Symbol
ADMA on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
237M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
218M
Holdings value
$3.2B
% of all portfolios
0.01%
Grand Portfolio weight change
+0%
Number of holders
357
Number of buys
159
Number of sells
-226
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.1% $866M 35.9M BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 8.94% $389M 21.4M The Vanguard Group 30 Jun 2025
Invesco Ltd. 5.4% +12% $310M $37.9M 12.9M +13.9% Invesco Ltd. 31 Mar 2025
STATE STREET CORP 5.1% +6% $222M $11.7M 12.1M +5.57% STATE STREET CORPORATION 30 Jun 2025

Institutional Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 218M $3.2B +$70.8M $14.66 357
2025 Q2 211M $3.84B +$78.9M $18.21 367
2025 Q1 205M $4.07B +$76.5M $19.84 342
2024 Q4 204M $3.5B -$114M $17.15 316
2024 Q3 207M $4.14B +$165M $19.99 300
2024 Q2 181M $2.03B +$84.9M $11.18 251
2024 Q1 174M $1.15B +$38.3M $6.60 213
2023 Q4 169M $765M -$2.94M $4.52 184
2023 Q3 171M $613M +$20M $3.58 188
2023 Q2 165M $611M +$2.42M $3.69 178
2023 Q1 165M $547M +$39.1M $3.31 161
2022 Q4 153M $592M +$84M $3.88 160
2022 Q3 130M $316M +$25.7M $2.43 126
2022 Q2 119M $236M +$28.8M $1.98 106
2022 Q1 105M $190M +$15.2M $1.83 101
2021 Q4 97.2M $137M +$69.6M $1.41 79
2021 Q3 41.6M $47M -$1.9M $1.13 65
2021 Q2 42.9M $68.6M -$9.32M $1.60 77
2021 Q1 48.5M $85.4M +$4.58M $1.76 99
2020 Q4 45.1M $88M -$3.26M $1.95 88
2020 Q3 46.2M $110M -$6.64M $2.39 89
2020 Q2 48.8M $143M +$1.13M $2.93 95
2020 Q1 48.5M $140M +$45.1M $2.88 90
2019 Q4 32.5M $130M -$5.34M $4.00 74
2019 Q3 37.2M $165M +$10.1M $4.45 71
2019 Q2 35M $136M +$49.5M $3.87 67
2019 Q1 22.3M $84.5M -$8.43M $3.79 54
2018 Q4 24.7M $58M -$3.59M $2.39 49
2018 Q3 26.6M $165M +$8.76M $6.21 56
2018 Q2 25.5M $115M +$41.3M $4.51 53
2018 Q1 17M $78M -$211K $4.60 34
2017 Q4 17M $54.7M +$27.5M $3.21 23
2017 Q3 8.45M $26M -$2.12M $3.08 17
2017 Q2 8.91M $33.2M -$1.18M $3.70 19
2017 Q1 9.23M $45M -$611K $4.88 17
2016 Q4 9.37M $48M -$551K $5.12 17
2016 Q3 9.48M $68.7M +$189K $7.24 18
2016 Q2 9.52M $57.4M +$6.75M $5.95 27
2016 Q1 8.39M $67.9M -$263K $8.09 21
2015 Q4 8.42M $68M -$508K $8.07 24
2015 Q3 7.05M $58.9M +$163K $8.36 23
2015 Q2 3.42M $31.7M +$721K $9.26 22
2015 Q1 6.95M $32.8M +$9.2M $9.80 18
2014 Q4 2.37M $26.4M +$14.3M $11.17 11
2014 Q3 777K $8M +$1.13M $10.30 1
2014 Q2 667K $6.5M +$6.5M $9.75 1